News
-
-
COMMUNIQUÉ DE PRESSE
Alzchem Group AG: Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052 - 9th Interim Report
Alzchem Group AG published its 9th Interim Report, revealing the acquisition of 8,730 shares as part of the share buyback program. Detailed information available on the company's website -
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Expansion of the Board of Directors of Baader Bank
Baader Bank expands its Board of Directors by appointing Mr Martin Zoller as the new Chief Risk Officer (CRO), effective from 1 March 2025. Mr Zoller brings 20 years of experience in risk management within the banking and securities industry -
COMMUNIQUÉ DE PRESSE
Formycon AG informs about recent developments in various biosimilar projects and invites to conference call
Formycon AG provides updates on various biosimilar projects, including terminating phase III trial for FYB206. Conference call on Feb 17, 2025, to discuss recent developments